Science Explorer Back to mapMap
Discussion
Researcher · UCB Pharma (United Kingdom) · United Kingdom

Jay Tibbitts

Jay Tibbitts publishes mostly in Oncology, Radiology, Nuclear Medicine and Imaging and Immunology, on topics such as Monoclonal and Polyclonal Antibodies Research, HER2/EGFR in Cancer Research and Radiopharmaceutical Chemistry and Applications.

OpenAlex
World rank
#526,191
of 7,710,434 ranked researchers
Rank in United Kingdom
#45,573
of 367,258
Works
121
Citations
4.3k
Citations per work
35.9
h-index
25
i10-index 38Top 16% in Oncology
Jay Tibbitts

What does Jay Tibbitts research?

Jay Tibbitts's work is mostly in Medicine (64%), Immunology and Microbiology (6%), Biochemistry, Genetics and Molecular Biology (5%).

Health Sciences: 77 works · 63.6% of their workMedicine: 77 works · 63.6% of their workOncology: 34 works · 28.4% of their workRadiology, Nuclear Medicine and Imaging: 32 works · 26.6% of their workPulmonary and Respiratory Medicine: 5 works · 4.5% of their workEpidemiology: 5 works · 4.1% of their workEverything else: 30 works · 25.1% of their workLife Sciences: 14 works · 11.3% of their workImmunology and Microbiology: 8 works · 6.3% of their workImmunology: 8 works · 6.3% of their workBiochemistry, Genetics and Molecular Biology: 6 works · 5.0% of their workMolecular Biology: 6 works · 5.0% of their workTHEIR WORKJay Tibbitts121works
Life Sciences11%Health Sciences64%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine7763.6%
  2. Everything else3025.1%
    1. Immunology and Microbiology86.3%
    2. Biochemistry, Genetics and Molecular Biology65.0%
  1. 1Oncology28% of their works
  2. 2Radiology, Nuclear Medicine and Imaging27% of their works
  3. 3Immunology6% of their works
  4. 4Molecular Biology5% of their works
  5. 5Pulmonary and Respiratory Medicine4% of their works
  6. 6Epidemiology4% of their works

Research topics

Which keywords describe Jay Tibbitts's research?

The keywords of their largest research topics: Monoclonal Antibodies, Breast Cancer, Fc Receptors, Therapeutic Antibodies, HER2, Trastuzumab, PET Imaging and Radiopharmaceuticals.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Monoclonal Antibodies542 topics
  2. Breast Cancer462 topics
  3. Fc Receptors441 topic
  4. Therapeutic Antibodies441 topic
  5. HER2411 topic
  6. Trastuzumab411 topic
  7. PET Imaging131 topic
  8. Radiopharmaceuticals131 topic
  9. CAR T Cells111 topic
  10. Chimeric Antigen Receptor111 topic
  11. Biosimilars101 topic
  12. Immunogenicity101 topic
  13. Metastatic Breast Cancer92 topics
  14. NAFLD81 topic
  15. NASH81 topic
  16. CDK4/6 Inhibitors51 topic
  17. Palbociclib51 topic
  18. Chemotherapy-Induced Peripheral Neuropathy41 topic
  19. Taxanes41 topic

Where does Jay Tibbitts work?

Jay Tibbitts's main affiliation in the publication record is UCB Pharma (United Kingdom), United Kingdom.

How many publications and citations does Jay Tibbitts have?

OpenAlex counts 121 works and 4,340 citations for Jay Tibbitts, an h-index of 25, ranking #526,191 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Jay Tibbitts. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.